CYCCP - Cyclacel Pharmaceuticals Inc
5.85
0 0%
Share volume: 0
Last Updated: 01-02-2025
PREVIOUS CLOSE
CHG
CHG%
$5.85
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-12-2024 | |
| Total revenue | 20.000 K | |
| Cost of revenue | 0.000 | |
| Gross profit | 20.000 K | |
| Operating expenses | 2.187 M | |
| Selling general and admin | 1.237 M | |
| Research and development | 950.000 K | |
| Total expenses | 2.187 M | |
| Operating income | -2.177 M | |
| Ebit | -2.175 M | |
| Pretax income | -2.167 M | |
| Income tax | -210.000 K | |
| Net income basic | 0.000 | |
| Net income | -1.957 M | |